45
Participants
Start Date
October 31, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Mirikizumab- IV
Administered IV
Mirikizumab - SC
Administered SC
Placebo - IV
Administered IV
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Waterloo
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Montreal
Eli Lilly and Company
INDUSTRY